The McGill Innovation Fund (MIF) is back for a 6th year. The largest entrepreneurial funding competition at McGill, the MIF has supported over 30 unique teams and awarded close to $2 million in...
The AMR data repository, hosted by the Infectious Diseases Data Observatory (IDDO), now covers nearly 70 countries and 783,000 patients, after launching last year to provide a secure, sustainable...
Life just got more difficult for those fighting antibiotic-resistant superbugs. Researchers at McGill University have discovered two enzymes that use a never-before-seen mechanism to confer...
Entrepreneurial spirit is thriving at McGill, as shown by a record-breaking 31 applications to the McGill Innovation Fund (MIF) this year. Since its inception in 2020, the MIF has been a catalyst...
Antimicrobial resistance (AMR) is one of the top ten global health threats and poses a major risk to public health and the economy. As the threat continues to increase, it is vital that...
The world is on the brink of a silent pandemic—one where currently treatable infections risk becoming once again life-threatening. This looming danger is Antimicrobial Resistance (AMR), a...
McGill University and Desjardins Group are teaming up to support research-based innovation. North America’s largest co-operative financial group will provide the McGill Innovation Fund (MIF) – the...
On August 13, the Honourable Mark Holland, Minister of Health, announced that the Government of Canada is investing more than $43 million to support 14 new clinical trials focused on preparing...